PULMATRIX, INC. Accounts Payable and Other Accrued Liabilities, Current
PULMATRIX, INC. (PULM) had Accounts Payable and Other Accrued Liabilities, Current of $32.00 thousand as of 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2015-06-10
- 2015-03-31: Accounts Payable and Other Accrued Liabilities, Current $32.00K.
- 2014-12-31: Accounts Payable and Other Accrued Liabilities, Current $16.00K.
- 2014-09-30: Accounts Payable and Other Accrued Liabilities, Current $189.00K.
- 2014-06-30: Accounts Payable and Other Accrued Liabilities, Current $125.00K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2015-03-31 | $32.00K 10-K · filed 2015-06-10 | |
| 2014-12-31 | $16.00K 10-Q · filed 2015-02-13 | |
| 2014-09-30 | $189.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $125.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $14.00K 10-K · filed 2015-06-10 | $15.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |